Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 929 blog entries.

July 2026

Tribun Health Announces CaloPix® 6, Its First IVDR-Certified Version for Routine Diagnostic Use

2026-10-05T09:24:40+00:00

A major new milestone in the digital transformation of pathology, benefiting laboratories, clinicians, and patients. Following FDA clearance in 2025, CaloPix’s® IVDR certification confirms Tribun Health’s ability to serve the global digital pathology market. Tribun Health, a global leader in digital pathology and artificial intelligence orchestration software solutions, today announced the availability of CaloPix® 6, [...]

Tribun Health Announces CaloPix® 6, Its First IVDR-Certified Version for Routine Diagnostic Use2026-10-05T09:24:40+00:00

Indica Labs Expands into Prostate Cancer, Improving NGS Confidence Through Precise Tumor Quantification

2026-07-09T15:42:01+00:00

Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the launch of Prostate Macrodissect AI, a clinically validated algorithm designed to automate and quantify tumor content in FFPE prostate tissue specimens. Prostate Macrodissect AI is designed to operate in concert with Indica Labs’ broader HALO Clinical AI suite, enabling laboratories to build end-to-end [...]

Indica Labs Expands into Prostate Cancer, Improving NGS Confidence Through Precise Tumor Quantification2026-07-09T15:42:01+00:00

Stockport NHS Foundation Trust Advances Pathology Transformation with Clinisys™ WinPath

2026-07-09T10:18:48+00:00

Stockport NHS Foundation Trust has successfully completed the full deployment of the Clinisys™ WinPath Laboratory Information Management System (LIMS), marking a significant milestone in its ongoing digital transformation of pathology services. The final phase of the go-live, covering blood transfusion and blood sciences, was completed on 20 April 2026, following an earlier implementation across microbiology and [...]

Stockport NHS Foundation Trust Advances Pathology Transformation with Clinisys™ WinPath2026-07-09T10:18:48+00:00

Court Halts FDA Rule on Lab-Developed Tests: What It Means for Pathology

2026-07-06T12:52:03+00:00

In this urgent and deeply personal episode of the Digital Pathology Podcast, I break down the major legal victory that’s sending ripples through our field: a federal court has just vacated the FDA’s final rule that would have classified Lab-Developed Tests (LDTs) as medical devices under the Federal Food, Drug, and Cosmetic Act. Had this rule gone into effect, labs across the [...]

Court Halts FDA Rule on Lab-Developed Tests: What It Means for Pathology2026-07-06T12:52:03+00:00

June 2026

Royal Cornwall Hospitals NHS Trust Goes Live with ULTRA LIS

2026-09-29T18:09:33+00:00

Following on from the successful implementation of ULTRA for Cellular Pathology in December 2025, Cirdan’s dedicated team was on site in May to support the successful go-live of ULTRA across several disciplines, including Immunology, Molecular, Transfusion Medicine, Coagulation Optimisation, Haematology, Biochemistry, Cellular Pathology, Microbiology, and Virology. This milestone is a testament to the continued strong collaboration, [...]

Royal Cornwall Hospitals NHS Trust Goes Live with ULTRA LIS2026-09-29T18:09:33+00:00

Conversation with Dr Julia Jones, Elsa Santos and Cara Brodie, Cancer Research UK Cambridge Institute – Episode 1

2026-09-14T09:11:55+00:00

Cancer Research UK: Driving Innovation in Digital Pathology and Spatial Biology In this episode, Sidney Ocanagil-Tunstall visits the Cancer Research UK Cambridge Institute to explore how digital pathology and spatial biology are transforming cancer research. Joined by Dr Julia Jones, Scientific Manager for In Situ Hybridisation, alongside Senior Scientific Associates Elsa Santos and Cara Brodie, [...]

Conversation with Dr Julia Jones, Elsa Santos and Cara Brodie, Cancer Research UK Cambridge Institute – Episode 12026-09-14T09:11:55+00:00

Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument

2026-07-02T15:12:09+00:00

Leveraging trusted automation from Leica Biosystems, the new offering helps researchers move from tissue sample to biological insight faster through more flexible, higher-plex immunofluorescence Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today announced the release of HCR™ Gold IF on the BOND RX research staining instrument from Leica Biosystems, a Danaher company and global leader in [...]

Molecular Instruments Advances Automated Multiplex Tissue Research with HCR™ Gold IF on the BOND RX Research Staining Instrument2026-07-02T15:12:09+00:00

Reporting in INFINITT PACS 7.0: Interoperability Is the Key

2026-07-02T09:05:22+00:00

In the age of AI and increasing system connectivity, interoperable solutions and collaborative partnerships are becoming ever more important. In radiology in particular, they open up new possibilities for making workflows more efficient, providing innovative functionalities, and meaningfully integrating artificial intelligence into reporting.A joint initiative by INFINITT Europe and EDL was presented during a session in the [...]

Reporting in INFINITT PACS 7.0: Interoperability Is the Key2026-07-02T09:05:22+00:00

Micro Highlight #37 – AI in Pathology and Laboratory Medicine: Managing Governance, Risk, and Accountability

2026-07-03T09:22:54+00:00

Artificial intelligence is rapidly moving from concept to practical application in pathology and laboratory medicine, with emerging use cases ranging from digital pathology algorithms and diagnostic decision support to workflow automation, quality monitoring, and administrative efficiency. As adoption accelerates, pathology practices and laboratories face growing questions regarding compliance oversight, data privacy, vendor accountability, professional liability, and responsible [...]

Micro Highlight #37 – AI in Pathology and Laboratory Medicine: Managing Governance, Risk, and Accountability2026-07-03T09:22:54+00:00

Stockholm3–Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up

2026-07-01T08:15:13+00:00

The following abstract is drawn from a recently published paper in Annals of Internal Medicine. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Thorgerdur Palsdottir, PhD, Chiara Micoli, MSc, [...]

Stockholm3–Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up2026-07-01T08:15:13+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top